Most not long ago, it has been recognized that conolidine and the above derivatives act on the atypical chemokine receptor three (ACKR3. Expressed in similar areas as classical opioid receptors, it binds to the wide array of endogenous opioids. Contrary to most opioid receptors, this receptor acts for a scavenger and will not activate a 2nd messeng